Key result
Sex hormones and life stages influence the development, progression, and treatment of diabetic kidney disease.
Why the study?
The role of sex as a risk factor in the development and progression of diabetic kidney disease remains unclear, complicated by general diabetes factors and sex-specific hormonal influences.
This review highlights the complex interplay between biological sex, sex hormones, and the pathophysiology of diabetic kidney disease.
Differences between the sexes exist in many diseases, and in most cases, being a specific sex is considered a risk factor in the development and/or progression. This is not quite so clear in diabetic kidney disease (DKD), the development and severity of which depends on many general factors, such as the duration of diabetes mellitus, glycemic control, and biological risk factors. Similarly, sex-specific factors, such as puberty or andro-/menopause, also determine the microvascular complications in both the male and female sex. In particular, the fact that diabetes mellitus itself influences sex hormone levels, which in turn seem to be involved in renal pathophysiology, highlights the complexity of the question of sex differences in DKD. The major objective of this review is to summarize and simplify the current knowledge on biological sex-related aspects in the development/progression but also treatment strategies of human DKD. It also highlights findings from basic preclinical research that may provide explanations for these differences.
No takes yet. Share an insight, caveat, or question.
Loeffler et al. (2023) conducted a review in Diabetic kidney disease. Biological sex-related aspects, including sex hormone levels and life stages, play a complex role in the development, progression, and treatment of diabetic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: